Barcelona, May 2017 – Prous Institute for Biomedical Research announced today that it has made a strategic investment in Chemotargets SL. Founded by Dr. Jordi Mestres as a spin-off of...
Read MoreChemotargets Featured in La Vanguardia: Celebrating 20 Years of Computational Excellence
Barcelona, March 2, 2026 – Today, the prominent Spanish newspaper La Vanguardia published a featured article on Chemotargets, highlighting the…
Read More
